As I indicated in my remarks, we participated early on in the Canada Gazette process. We follow the briefings through the webinar process. We have had the opportunity to go in and present our views to the negotiators. As well, we are part of the International Generic Pharmaceutical Alliance, so we exchange information amongst our colleagues in other countries in the generic pharmaceutical industry. So through those mechanisms, yes, we have had opportunity to make our views known.
On March 27th, 2014. See this statement in context.